pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 371 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
zilucoplan
Zilbrysq (zilucoplan)
Myasthenia Gravis
UCB SA
6 catalysts
Marketed
belumosudil mesylate
Rezurock (belumosudil mesylate)
Graft Versus Host Disease (GVHD)
Kadmon Pharmaceuticals LLC
5 catalysts
Marketed
mycophenolate sodium DR
Mycophenolate Sodium (mycophenolate sodium)
Kidney Transplant Rejection
Wanbang Biopharmaceuticals Co Ltd
3 catalysts
← prev
page 2 of 13
next →
131
Pain89
Neurology1
Marketed
ustekinumab biosimilar
Imuldosa (ustekinumab-kfce)
Psoriatic Arthritis
Accord Biopharma Inc
6 catalysts
Marketed
adalimumab
Humira (adalimumab)
Intermediate Uveitis
$ABBVAbbVie Inc.
61 catalysts
Marketed
apremilast
Apremilast (apremilast)
Plaque Psoriasis (Psoriasis Vulgaris)
Annora Pharma Pvt Ltd
14 catalysts
Marketed
berotralstat hydrochloride
Orladeyo (berotralstat hydrochloride)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$BCRXBIOCRYST PHARMACEUTICALS INC
5 catalysts
Marketed
obinutuzumab
Gazyva (obinutuzumab)
Systemic Lupus Erythematosus
B-lymphocyte antigen CD20
F. Hoffmann-La Roche Ltd
14 catalysts
Marketed
depemokimab
Exdensur (depemokimab-ulaa)
Nasal Polyps (Nasal Polyposis)
$GSKGSK plc
1 catalysts
Marketed
rozanolixizumab
Rystiggo (rozanolixizumab-noli)
Myasthenia Gravis
UCB SA
3 catalysts
Marketed
omalizumab biosimilar
Omlyclo (OMALIZUMAB-IGEC)
Food Allergy
Immunoglobulin heavy constant epsilon
Kashiv BioSciences LLC
2 catalysts
Marketed
sibeprenlimab
Voyxact (sibeprenlimab-szsi)
Sicca Syndrome (Sjogren)
Visterra Inc
1 catalysts
Marketed
CLADRIBINE
CLADRIBINE (CLADRIBINE)
Relapsing Remitting Multiple Sclerosis (RRMS)
EMD Serono Inc
1 catalysts
Marketed
TAZAROTENE
TAZAROTENE (TAZAROTENE)
Idiopathic Pulmonary Fibrosis
Retinoic acid receptor
$GRIGRI Bio, Inc.
1 catalysts
Marketed
Clobetasol Propionate Teva
Clobetasol Propionate (clobetasol propionate)
Atopic Dermatitis (Atopic Eczema)
Teva Pharmaceuticals USA Inc
1 catalysts
Marketed
methylprednisolone sodium succinate
Methylprednisolone Sodium Succinate (methylprednisolone sodium succinate)
Drug Hypersensitivity Reactions
Sagent Pharmaceuticals Inc
48 catalysts
Marketed
sulfasalazine DR
Sulfasalazine Greenstone (sulfasalazine)
Juvenile Rheumatoid Arthritis
Greenstone LLC
1 catalysts
Marketed
infliximab biosimilar
Renflexis (infliximab-abda)
Pulmonary Sarcoidosis
Tumor necrosis factor
Xentria Inc
6 catalysts
Marketed
LEFLUNOMIDE
LEFLUNOMIDE (LEFLUNOMIDE)
Rheumatoid Arthritis
Abhai Inc
8 catalysts
Marketed
NEOSTIGMINE METHYLSULFATE
NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)
Acetylcholinesterase
$AMPHAmphastar Pharmaceuticals, Inc.
3 catalysts
Marketed
spesolimab
Spevigo (spesolimab)
Pyoderma Gangrenosum
IL36 receptor
Boehringer Ingelheim International GmbH
5 catalysts
Marketed
tacrolimus ER
Envarsus XR (tacrolimus)
Kidney Transplant Rejection
Veloxis Pharmaceuticals Inc
8 catalysts
Marketed
triamcinolone acetonide Rising
Triamcinolone Acetonide (triamcinolone acetonide)
Atopic Dermatitis (Atopic Eczema)
Rising Pharma Holdings Inc
6 catalysts
Marketed
upadacitinib tartrate ER
Rinvoq (upadacitinib tartrate)
Vitiligo
$ABBVAbbVie Inc.
19 catalysts
Marketed
voclosporin
Lupkynis (voclosporin)
Lupus Nephritis
$AUPHAurinia Pharmaceuticals Inc.
3 catalysts
Marketed
calcipotriene
Calcipotriene Prasco (calcipotriene)
Plaque Psoriasis (Psoriasis Vulgaris)
Prasco LLC
25 catalysts
Marketed
NAPROXEN
NAPROXEN (NAPROXEN)
Primary Dysmenorrhea
Hikma Pharmaceuticals USA Inc
1 catalysts
Marketed
PILOCARPINE HYDROCHLORIDE
PILOCARPINE HYDROCHLORIDE (PILOCARPINE HYDROCHLORIDE)
Xerostomia
Innogenix Inc
1 catalysts
Marketed
guselkumab
Tremfya (guselkumab)
Psoriatic Arthritis
Interleukin-23
$JNJJOHNSON & JOHNSON
14 catalysts
Marketed
certolizumab pegol
Cimzia (certolizumab pegol)
Ankylosing Spondylitis (Bekhterev's Disease)
UCB SA
35 catalysts